Holen Sie sich die Stockscreener-App
105.65
1.95%
-2.11
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
BSX: Boston Scientific Sees Price Target Raised by Truist Securi - GuruFocus
Boston Scientific (BSX) Price Target Raised by Baird Analyst | B - GuruFocus
Boston Scientific (BSX) Price Target Raised to $118 by Oppenheimer | BSX Stock News - GuruFocus
UBS Boosts Price Target for Boston Scientific (BSX) Amid Strong Performance | BSX Stock News - GuruFocus
Boston Scientific stock price target raised to $124 by Wells Fargo on PFA growth - Investing.com
Boston Scientific (BSX) Sees Price Target Boost from Barclays | - GuruFocus
Boston Scientific’s Strong Financial Performance and Positive Outlook Earns Buy Rating - TipRanks
Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings? - Nasdaq
Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up - The Globe and Mail
Boston Scientific stock price target raised to $120 by BofA Securities - Investing.com
Boston Scientific (BSX) Price Target Increased by BofA Analyst | - GuruFocus
Boston Scientific Presses Its Advantage in Pulsed Field Ablation - Morningstar
Boston Scientific halves expected tariff hit - MedTech Dive
Boston Scientific Lifts Outlook On Cardiovascular Revenue Growth - Finimize
Boston Scientific lifts annual profit forecast, sees smaller tariff impact - Reuters
Boston Scientific lifts annual profit forecast, sees smaller tariff impact By Reuters - Investing.com
Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance - inkl
Boston Scientific stock hits all-time high at 107.76 USD - Investing.com
Boston Scientific stock hits all-time high at 107.76 USD By Investing.com - Investing.com UK
Earnings call transcript: Boston Scientific Q2 2025 beats expectations, stock rises - Investing.com
Boston Scientific lifts annual profit view on steady heart devices demand - Yahoo.co
Boston Scientific: Q2 Earnings Snapshot - CTPost
Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates - Nasdaq
Boston Scientific increases full-year guidance after Q2 beats - MassDevice
Boston Scientific Q2 2025 Earnings Outperform Guidance with 22.8% Sales Growth 13.6% EPS Rise - AInvest
Boston Scientific Corp (BSX) Q2 2025 Earnings: EPS of $0.53 Beats Estimate, Revenue Surges to $5.061 Billion - GuruFocus
Boston Scientific Boosts FY25 OutlookUpdate - Nasdaq
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Expectations - GuruFocus
Boston Scientific Q2 2025 slides: 22.8% sales growth fueled by Electrophysiology surge - Investing.com
Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide - Investing.com
Boston Scientific earnings beat by $0.02, revenue topped estimates - Investing.com
Boston Scientific Q2 2025 Financial Results - TradingView
Boston Scientific announces results for second quarter 2025 - Financial Times
Is Boston Scientific Corporation a good long term investmentTriple-digit returns - jammulinksnews.com
Boston Scientific (BSX) Anticipates Robust Q2 Earnings Growth - GuruFocus
FDA expands Boston Sci’s Watchman label to post-ablation - BioWorld MedTech
Raymond James maintains Strong Buy on Boston Scientific stock - Investing.com
Boston Scientific Watchman wins FDA expansion for post-ablation patients - MassDevice
Boston Scientific stock set to beat Q2 estimates, says TD Cowen - Investing.com
Boston Scientific: Strong Growth Potential and Positive Outlook Justify Buy Rating - TipRanks
What analysts say about Boston Scientific Corporation stockBreakthrough stock performance - printweek.in
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System - MSN
Boston Scientific’s Innovation Drive Keeps The Stock Climbing - Finimize
Lobbying Update: $570,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq
Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Is Boston Scientific Corporation (NYSE:BSX) Worth US$103 Based On Its Intrinsic Value? - Yahoo Finance
Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings? - MSN
Boston Scientific receives US FDA approval for expanded labelling of Farapulse pulsed field ablation system - Cardiac Rhythm News
Boston Scientific (BSX): A High-Stakes Gamble on Innovation Ahead of Q2 Earnings - AInvest
Why Boston Scientific (BSX) Outpaced the Stock Market Today - Yahoo Finance
Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships - Yahoo Finance
13 Best Large Cap Stocks to Buy Right Now - Insider Monkey
Boston Scientific’s (BSX) FARAPULSE Approved by FDA for Expanded Labeling - Insider Monkey
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):